Variant report
Variant | nsv466927 |
---|---|
Chromosome Location | chr1:190684263-190719032 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RGS18-4 | chr1:190707568-190707640 | ENSG00000231175.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145662365 | chr1:190707578-190707579 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs574950523 | chr1:190707579-190707580 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs79312575 | chr1:190707580-190707581 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs560845247 | chr1:190707587-190707588 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs148901014 | chr1:190707588-190707589 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs539267494 | chr1:190707601-190707602 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs572028961 | chr1:190707610-190707611 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs79706560 | chr1:190709007-190709008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183049498 | chr1:190709014-190709015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188430745 | chr1:190709055-190709056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs59739924 | chr1:190709086-190709087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534964640 | chr1:190709099-190709100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144690636 | chr1:190709104-190709105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12135407 | chr1:190709144-190709145 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs191170533 | chr1:190709152-190709153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148213222 | chr1:190709153-190709154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576529462 | chr1:190709167-190709168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542396366 | chr1:190709332-190709333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35013866 | chr1:190709333-190709334 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs201359497 | chr1:190709335-190709336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183779415 | chr1:190709351-190709352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117040327 | chr1:190709370-190709371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199720475 | chr1:190709379-190709380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566899624 | chr1:190709389-190709390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141537897 | chr1:190709393-190709394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150875236 | chr1:190709400-190709401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536488986 | chr1:190709413-190709414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549584048 | chr1:190709433-190709434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74129784 | chr1:190709476-190709477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138352278 | chr1:190709501-190709502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10429896 | chr1:190709600-190709601 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs549157800 | chr1:190709634-190709635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35864653 | chr1:190709647-190709648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs397783698 | chr1:190709652-190709653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565922644 | chr1:190709653-190709654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144098623 | chr1:190709703-190709704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187401572 | chr1:190709710-190709711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569438435 | chr1:190709719-190709720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570829019 | chr1:190709734-190709735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533985493 | chr1:190715013-190715014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576662520 | chr1:190715015-190715016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548844977 | chr1:190715045-190715046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542124980 | chr1:190715098-190715099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561297065 | chr1:190715108-190715109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527308744 | chr1:190715110-190715111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190471526 | chr1:190715149-190715150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564195298 | chr1:190715164-190715165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79194549 | chr1:190715191-190715192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567313928 | chr1:190715194-190715195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189235922 | chr1:190715204-190715205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:190709000-190709800 | Enhancers | Fetal Heart | heart |
2 | chr1:190715000-190717800 | Enhancers | Fetal Lung | lung |
3 | chr1:190716400-190717400 | Enhancers | Adipose Nuclei | Adipose |
4 | chr1:190716400-190717400 | Enhancers | Hela-S3 | cervix |
5 | chr1:190716400-190717800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr1:190717800-190723400 | Weak transcription | Fetal Lung | lung |